ProFactor Pharma LTD
  • Home
  • About Us
  • Haemophilia
  • Technology
  • Team
  • Contact
  • News
Select Page

Contact

    ProFactor Pharma Ltd

    C/O Ingenza Limited

    Roslin Innovation Centre

    Charnock Bradley Building

    Roslin

    Midlothian EH25 9R

    Articles

    • PFP executives visit Bio Farma to kick start Tech Transfer process – January 2023 January 26, 2023
    • Low-cost Haemophilia A treatment deal unlocks world of opportunity  October 19, 2022
    • ProFactor Pharma (PFP) realise further capital injection – August 2022 September 20, 2022
    • Health Tech World – Interview – Ending the Haemophilia Drug Shortage (23 November 2021) November 24, 2021
    • Profactor Pharma Announces Issuance of Indian and Eurasian Patent Covering a high yielding cell line for treatment of Haemophilia A March 31, 2021
    • Profactor Pharma completes optimisation of process for manufacture of lowest cost recombinant FVIII January 31, 2021
    • World-wide inequalities in Haemophilia care. Things are getting better? January 19, 2021
    • Outstanding technical progress July 15, 2020
    • Too many Haemophilia A patients still receiving inadequate or no treatment January 26, 2020
    • Paul Gerskowitch Joins PFP Board November 15, 2019
    • Home
    • About Us
    • Haemophilia
    • Technology
    • Team
    • Contact
    • News